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Synthetic cannabinoids (SCs) has hundreds of street names for instance “Spice”, “Spice 
Gold”, “K2”, “Black Mamba”, “Feek Weed,” “Genie”. SCs are group of designer drugs that 
mimic the natural cannabinoid effects. However, SCs have significantly higher binding 
affinities to the CB1 and CB2 cannabinoid receptors than the well-known Δ⁹-
tetrahydrocannabinol (THC) thanks to their special pharmacodynamic properties. In clinical 
and forensic practices only detecting the mother compound of SCs cannot provide reliable 
confirmation of their consumption due to their rapid metabolism. The aims of this study were 
in vitro (human liver microsome, immortalized human hepatocytes), in vivo (human urine and 
blood) and ex vivo (isolated rat liver perfusion) analysis of metabolites of the newest designer 
drugs in 2019. After optimizing the sample preparation (liquid-liquid extraction), new 
targeted LC-MS/MS method was developed for detecting the parent molecule and its phase I 
metabolites. Currently, the most commonly used SC is the 5F-MDMB-PICA. The importance 
of identifying metabolites can be well demonstrated by extracted ion chromatogram of 
positive urine sample (Figure 1), which shows that the ester hydrolysis metabolite of 5F-




Figure 2. Positive urine sample 
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